Sickle cell Anemia: A worldwide popular blood disorder, basically a inheritable disease. This document provides you with basic introduction to blood, Anemia its general considerations, signs and symptoms and lastly about Sickle cell Anemia in detail.
Alpha thalassemia is caused by mutations in the genes responsible for producing alpha globin, resulting in excessive destruction of red blood cells and anemia. It is characterized by mild to severe anemia, enlargement of the liver and spleen, and other symptoms. Treatment involves regular blood transfusions, folic acid supplements, and iron chelation therapy. Bone marrow transplant may cure severe cases. Beta thalassemia is caused by mutations in the beta globin gene and is characterized by severe anemia and other symptoms from an early age. Treatment focuses on blood transfusions and iron chelation therapy.
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyThe Medical Post
This document discusses hereditary spherocytosis and G6PD deficiency, two causes of hemolytic anemia. Hereditary spherocytosis is caused by a defect in the red blood cell membrane that results in spherical shaped red blood cells. G6PD deficiency results in hemolytic anemia during times of oxidative stress due to the lack of an enzyme, glucose-6-phosphate dehydrogenase, that protects red blood cells. The document describes the clinical presentations, treatments, and diagnostic testing for each condition.
Thalassemia is a blood disorder caused by variants or missing genes that affect hemoglobin production. There are two main types: alpha thalassemia affects alpha globin gene expression, while beta thalassemia is caused by a deficiency in beta globin production. People with beta thalassemia experience anemia and other health issues due to the lack of functional hemoglobin in red blood cells. Treatment involves regular blood transfusions combined with iron chelation therapy or bone marrow transplants in severe cases.
This document discusses megaloblastic anemia, which is caused by vitamin B12 or folate deficiency and results in abnormal red blood cell maturation in the bone marrow. The primary defect is in DNA synthesis, leading to large immature red blood cells called megaloblasts. This causes hypercellular bone marrow with megaloblasts and giant neutrophils. Peripheral blood smears show macrocytic anemia, hypersegmented neutrophils, and poikilocytosis. Diagnosis involves blood tests of vitamin B12, methylmalonic acid, and homocysteine. Pernicious anemia, the most common cause of B12 deficiency, is an autoimmune condition that lacks intrinsic factor. Non-me
This document summarizes hereditary hemolytic anemias caused by abnormalities in the red blood cell membrane, specifically hereditary spherocytosis and elliptocytosis. It describes the pathophysiology as defects in membrane proteins like spectrin or ankyrin that cause unstable membranes. Clinical features include anemia, splenomegaly, jaundice and gallstones. Laboratory findings show microspherocytes on blood smear and increased osmotic fragility. G6PD deficiency and pyruvate kinase deficiency are also summarized as enzymatic causes of hemolytic anemia that present with hemolysis when exposed to oxidative stress or inability to generate ATP respectively.
Alpha thalassemia is caused by mutations in the genes responsible for producing alpha globin, resulting in excessive destruction of red blood cells and anemia. It is characterized by mild to severe anemia, enlargement of the liver and spleen, and other symptoms. Treatment involves regular blood transfusions, folic acid supplements, and iron chelation therapy. Bone marrow transplant may cure severe cases. Beta thalassemia is caused by mutations in the beta globin gene and is characterized by severe anemia and other symptoms from an early age. Treatment focuses on blood transfusions and iron chelation therapy.
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyThe Medical Post
This document discusses hereditary spherocytosis and G6PD deficiency, two causes of hemolytic anemia. Hereditary spherocytosis is caused by a defect in the red blood cell membrane that results in spherical shaped red blood cells. G6PD deficiency results in hemolytic anemia during times of oxidative stress due to the lack of an enzyme, glucose-6-phosphate dehydrogenase, that protects red blood cells. The document describes the clinical presentations, treatments, and diagnostic testing for each condition.
Thalassemia is a blood disorder caused by variants or missing genes that affect hemoglobin production. There are two main types: alpha thalassemia affects alpha globin gene expression, while beta thalassemia is caused by a deficiency in beta globin production. People with beta thalassemia experience anemia and other health issues due to the lack of functional hemoglobin in red blood cells. Treatment involves regular blood transfusions combined with iron chelation therapy or bone marrow transplants in severe cases.
This document discusses megaloblastic anemia, which is caused by vitamin B12 or folate deficiency and results in abnormal red blood cell maturation in the bone marrow. The primary defect is in DNA synthesis, leading to large immature red blood cells called megaloblasts. This causes hypercellular bone marrow with megaloblasts and giant neutrophils. Peripheral blood smears show macrocytic anemia, hypersegmented neutrophils, and poikilocytosis. Diagnosis involves blood tests of vitamin B12, methylmalonic acid, and homocysteine. Pernicious anemia, the most common cause of B12 deficiency, is an autoimmune condition that lacks intrinsic factor. Non-me
This document summarizes hereditary hemolytic anemias caused by abnormalities in the red blood cell membrane, specifically hereditary spherocytosis and elliptocytosis. It describes the pathophysiology as defects in membrane proteins like spectrin or ankyrin that cause unstable membranes. Clinical features include anemia, splenomegaly, jaundice and gallstones. Laboratory findings show microspherocytes on blood smear and increased osmotic fragility. G6PD deficiency and pyruvate kinase deficiency are also summarized as enzymatic causes of hemolytic anemia that present with hemolysis when exposed to oxidative stress or inability to generate ATP respectively.
Thalassemia is a genetic blood disorder caused by mutations in the genes that control globin production. There are two main types - alpha thalassemia affects alpha globin genes, while beta thalassemia affects beta globin genes. Thalassemia severity depends on the number of affected genes, ranging from no symptoms to severe anemia requiring chronic blood transfusions. The thalassemia gene is maintained in populations where malaria is common due to heterozygote resistance to the disease.
The document discusses thalassemia, a genetic blood disorder. It defines thalassemia and describes its prevalence worldwide. There are two main types - alpha and beta thalassemia - depending on which globin chain is deficient. Symptoms range from mild to severe anemia. The disorder is diagnosed through blood tests and analysis of red blood cells. Treatment involves blood transfusions and medication.
Bernard-Soulier syndrome is a rare inherited bleeding disorder characterized by large platelets and prolonged bleeding times. It results from mutations that cause a dysfunctional platelet glycoprotein receptor complex, leading to defective platelet adhesion. Patients present with mucocutaneous bleeding from an early age. Diagnosis involves identifying thrombocytopenia, large platelets on smear, and abnormal platelet aggregation tests. Treatment focuses on transfusions and minimizing trauma; stem cell transplantation may be considered for severe cases.
The document discusses the thalassemias, a group of inherited blood disorders caused by defects in hemoglobin synthesis. There are two main types: alpha thalassemia results from reduced alpha globin chain production, while beta thalassemia is caused by reduced beta globin chains. Symptoms range from none to severe anemia requiring blood transfusions, depending on the number of defective genes. Thalassemias are most common in people from Mediterranean, African, and Southeast Asian descent and are diagnosed based on blood tests showing microcytic anemia and abnormalities in hemoglobin electrophoresis and red blood cell indices.
Lysosomal storage diseases (LSDs) are a group of over 50 inherited metabolic disorders caused by defects in lysosomal function. The main types are sphingolipidoses, mucopolysaccharidoses, and glycoproteinoses. Symptoms often involve the brain and nervous system. On MRI, the corpus callosum may be not visualized or partially visualized in some LSDs. Histopathology reveals neuronal storage material, spheroids in white matter, and membranous cytoplasmic bodies in neurons. LSDs can also affect dogs and cats, with clinical signs appearing in early life and pathology showing tissue storage.
This document discusses β-thalassemia, a genetic blood disorder caused by mutations in the β-globin gene resulting in reduced or absent β-chain production and hemoglobin synthesis. It is characterized by microcytic hypochromic anemia and is most common around the Mediterranean sea. The degree of β-chain deficiency determines the severity from β° (no β-chains) to β++ (more β-chains). Clinical manifestations include anemia, jaundice, hepatosplenomegaly, skeletal abnormalities, and heart failure. Management involves blood transfusions, chelation therapy, and folic acid supplementation.
G6PD deficiency is a defect in the G6PD enzyme, which provides protection against oxidative stress in red blood cells. It is an X-linked inherited condition, though female heterozygotes have some protection against malaria. Those with G6PD deficiency experience hemolytic anemia during times of oxidative stress caused by factors like infections, medications, or foods like fava beans. The deficiency results in inadequate levels of NADPH and glutathione, leaving red blood cells vulnerable to damage and hemolysis. Symptoms of the acute hemolytic anemia appear 24-48 hours after exposure to the triggering agent. Laboratory tests show signs of hemolysis and low G6PD enzyme activity. There is no cure or treatment other than
The document discusses thalassemia, a group of inherited blood disorders characterized by reduced or absent globin chains. It covers the basics of alpha and beta thalassemia including genetic basis, classification, clinical outcomes, complications, and management approaches like transfusions, chelation therapy, splenectomy, and immunizations. Key points include the varying severity of alpha and beta thalassemia syndromes depending on which globin chains are affected, the risk of iron overload and related organ damage without proper chelation therapy, and the goal of splenectomy to reduce transfusion needs in severe cases.
Homocystinuria is a disorder of methionine metabolism caused by an inability to metabolize homocysteine. There are three main types: classic homocystinuria caused by cystathionine β-synthase deficiency; defects in methylcobalamin formation; and methylenetetrahydrofolate reductase deficiency. Symptoms vary but can include developmental delay, dislocated lenses, skeletal abnormalities, thromboembolism, and intellectual disability. Treatment depends on the type but may include vitamin B6, betaine, folic acid, vitamin B12, methionine supplementation, and dietary restrictions.
G6PD deficiency is caused by mutations in the G6PD gene resulting in reduced activity of the G6PD enzyme. This enzyme is critical for generating NADPH which protects red blood cells from oxidative damage. Lack of G6PD activity leads to hemolysis of red blood cells during times of oxidative stress from infections, drugs, or foods. The condition is diagnosed through screening tests detecting NADPH production or dye reduction, and confirmed by quantitative enzyme assays. Management focuses on preventing hemolysis through treating infections promptly and avoiding oxidative triggers. G6PD deficiency provides some protection against malaria in endemic areas.
Sickle cell anemia is caused by a genetic mutation that results in abnormal hemoglobin called HbS. When HbS is deoxygenated, it polymerizes inside red blood cells, causing them to take on a sickle or holly leaf shape. This leads to hemolysis, anemia, vaso-occlusive crises involving painful blockages in small blood vessels, and organ damage. The condition is most common where malaria is endemic, as the sickle cell trait provides resistance to that disease. Laboratory testing can demonstrate sickle cells on blood smears and the presence of HbS on electrophoresis.
Hemoglobin D is a structural hemoglobin variant caused by a point mutation in the beta globin gene. This document discusses the history and molecular basis of Hemoglobin D, its distribution worldwide including prevalence in Pakistani and Indian populations, clinical manifestations in different genotypes including heterozygous, homozygous, and compound heterozygous states with other hemoglobinopathies like beta thalassemia. It also summarizes several case reports of Hemoglobin D-beta thalassemia published in medical literature.
Lysosomal storage disorders are a group of inherited metabolic diseases caused by deficiencies of lysosomal enzymes. This results in the accumulation of substrates in the lysosomes which causes cellular dysfunction. Some examples discussed include Gaucher disease, Tay-Sachs disease, Niemann-Pick disease, and Fabry disease. The document provides an overview of the causes and characteristics of these lysosomal storage disorders.
This document summarizes information about glucose-6-phosphate dehydrogenase (G6PD) deficiency. It discusses how G6PD is important for generating NADPH and reducing power in red blood cells. G6PD deficiency results in oxidative damage and hemolysis of red blood cells due to a lack of reducing equivalents. Clinical manifestations range from asymptomatic to acute hemolytic anemia triggered by oxidative drugs, infections, or fava beans. Diagnosis involves screening tests to detect low G6PD enzyme activity in red blood cells.
This document discusses megaloblastic anemia caused by vitamin B12 or folic acid deficiency. It covers the absorption and causes of deficiencies of these vitamins, clinical features including hematological and bone marrow findings, and biochemical tests to diagnose the deficiencies. The key tests mentioned are serum B12, methylmalonic acid, homocysteine, Schilling test, and red blood cell and serum folate levels. Guidelines are provided on interpretation of the test results in the clinical context.
Megaloblastic anemias are caused by impaired DNA synthesis due to vitamin B12 or folate deficiency. The summary examines megaloblastic anemias, including causes such as vitamin B12 or folate metabolism defects, clinical features like pallor and neurological symptoms, investigation findings in peripheral blood and bone marrow showing megaloblasts and macroovalocytes, and treatment involving vitamin B12 or folate supplementation.
This document provides an overview of macrocytic anemia, including:
- Megaloblastic anemia is caused by vitamin B12 or folate deficiency and results in large, immature red blood cells (megaloblasts) in the bone marrow.
- Non-megaloblastic macrocytic anemias have other causes and do not involve megaloblasts.
- Workup of macrocytic anemia includes evaluation of mean corpuscular volume, red cell distribution width, blood counts, serum B12 and folate levels, and bone marrow examination showing megaloblasts in megaloblastic anemia.
- Treatment depends on the underlying cause but commonly involves B
Porphyria is caused by deficiencies in enzymes involved in heme biosynthesis, leading to accumulation of porphyrins and their precursors. There are several types of porphyria classified by enzyme deficiency, symptoms, or origin of excess precursors. Acute porphyrias involve neurologic or abdominal symptoms, while cutaneous porphyrias cause skin problems when exposed to sunlight. Porphyria results from partial deficiencies in enzymes that are sufficient under normal conditions but can be exacerbated by external factors, causing intermediates to accumulate and spill over.
This document provides an overview of anemia, including its classification, causes, clinical features, laboratory diagnosis, and pathophysiology.
Anemia is defined as a hemoglobin level below the normal range based on age and sex. It can be classified based on red blood cell size (microcytic, normocytic, macrocytic) or pathophysiology (blood loss, impaired RBC production, increased RBC destruction). Common causes include iron deficiency, B12/folate deficiency, blood loss, hemolytic disorders, and bone marrow disorders.
Clinical features depend on the severity and speed of onset of anemia. Laboratory evaluation includes complete blood count, RBC indices, peripheral smear, and additional
This document provides information on anaemia, including its definition, epidemiology, pathophysiology, clinical features, investigations, classification, and management. It begins by defining anaemia as a decreased red blood cell mass that can be detected by low haemoglobin, haematocrit, and red blood cell count. Globally, anaemia prevalence is high in developing countries, especially among women and children in Africa. The pathophysiology involves inadequate red blood cell production due to iron deficiency, vitamin deficiencies, or chronic diseases. Common causes include iron deficiency, vitamin B12/folate deficiency, and anaemia of chronic disease. A complete blood count, peripheral smear, and targeted lab tests can help classify and diagnose the specific type of
Thalassemia is a genetic blood disorder caused by mutations in the genes that control globin production. There are two main types - alpha thalassemia affects alpha globin genes, while beta thalassemia affects beta globin genes. Thalassemia severity depends on the number of affected genes, ranging from no symptoms to severe anemia requiring chronic blood transfusions. The thalassemia gene is maintained in populations where malaria is common due to heterozygote resistance to the disease.
The document discusses thalassemia, a genetic blood disorder. It defines thalassemia and describes its prevalence worldwide. There are two main types - alpha and beta thalassemia - depending on which globin chain is deficient. Symptoms range from mild to severe anemia. The disorder is diagnosed through blood tests and analysis of red blood cells. Treatment involves blood transfusions and medication.
Bernard-Soulier syndrome is a rare inherited bleeding disorder characterized by large platelets and prolonged bleeding times. It results from mutations that cause a dysfunctional platelet glycoprotein receptor complex, leading to defective platelet adhesion. Patients present with mucocutaneous bleeding from an early age. Diagnosis involves identifying thrombocytopenia, large platelets on smear, and abnormal platelet aggregation tests. Treatment focuses on transfusions and minimizing trauma; stem cell transplantation may be considered for severe cases.
The document discusses the thalassemias, a group of inherited blood disorders caused by defects in hemoglobin synthesis. There are two main types: alpha thalassemia results from reduced alpha globin chain production, while beta thalassemia is caused by reduced beta globin chains. Symptoms range from none to severe anemia requiring blood transfusions, depending on the number of defective genes. Thalassemias are most common in people from Mediterranean, African, and Southeast Asian descent and are diagnosed based on blood tests showing microcytic anemia and abnormalities in hemoglobin electrophoresis and red blood cell indices.
Lysosomal storage diseases (LSDs) are a group of over 50 inherited metabolic disorders caused by defects in lysosomal function. The main types are sphingolipidoses, mucopolysaccharidoses, and glycoproteinoses. Symptoms often involve the brain and nervous system. On MRI, the corpus callosum may be not visualized or partially visualized in some LSDs. Histopathology reveals neuronal storage material, spheroids in white matter, and membranous cytoplasmic bodies in neurons. LSDs can also affect dogs and cats, with clinical signs appearing in early life and pathology showing tissue storage.
This document discusses β-thalassemia, a genetic blood disorder caused by mutations in the β-globin gene resulting in reduced or absent β-chain production and hemoglobin synthesis. It is characterized by microcytic hypochromic anemia and is most common around the Mediterranean sea. The degree of β-chain deficiency determines the severity from β° (no β-chains) to β++ (more β-chains). Clinical manifestations include anemia, jaundice, hepatosplenomegaly, skeletal abnormalities, and heart failure. Management involves blood transfusions, chelation therapy, and folic acid supplementation.
G6PD deficiency is a defect in the G6PD enzyme, which provides protection against oxidative stress in red blood cells. It is an X-linked inherited condition, though female heterozygotes have some protection against malaria. Those with G6PD deficiency experience hemolytic anemia during times of oxidative stress caused by factors like infections, medications, or foods like fava beans. The deficiency results in inadequate levels of NADPH and glutathione, leaving red blood cells vulnerable to damage and hemolysis. Symptoms of the acute hemolytic anemia appear 24-48 hours after exposure to the triggering agent. Laboratory tests show signs of hemolysis and low G6PD enzyme activity. There is no cure or treatment other than
The document discusses thalassemia, a group of inherited blood disorders characterized by reduced or absent globin chains. It covers the basics of alpha and beta thalassemia including genetic basis, classification, clinical outcomes, complications, and management approaches like transfusions, chelation therapy, splenectomy, and immunizations. Key points include the varying severity of alpha and beta thalassemia syndromes depending on which globin chains are affected, the risk of iron overload and related organ damage without proper chelation therapy, and the goal of splenectomy to reduce transfusion needs in severe cases.
Homocystinuria is a disorder of methionine metabolism caused by an inability to metabolize homocysteine. There are three main types: classic homocystinuria caused by cystathionine β-synthase deficiency; defects in methylcobalamin formation; and methylenetetrahydrofolate reductase deficiency. Symptoms vary but can include developmental delay, dislocated lenses, skeletal abnormalities, thromboembolism, and intellectual disability. Treatment depends on the type but may include vitamin B6, betaine, folic acid, vitamin B12, methionine supplementation, and dietary restrictions.
G6PD deficiency is caused by mutations in the G6PD gene resulting in reduced activity of the G6PD enzyme. This enzyme is critical for generating NADPH which protects red blood cells from oxidative damage. Lack of G6PD activity leads to hemolysis of red blood cells during times of oxidative stress from infections, drugs, or foods. The condition is diagnosed through screening tests detecting NADPH production or dye reduction, and confirmed by quantitative enzyme assays. Management focuses on preventing hemolysis through treating infections promptly and avoiding oxidative triggers. G6PD deficiency provides some protection against malaria in endemic areas.
Sickle cell anemia is caused by a genetic mutation that results in abnormal hemoglobin called HbS. When HbS is deoxygenated, it polymerizes inside red blood cells, causing them to take on a sickle or holly leaf shape. This leads to hemolysis, anemia, vaso-occlusive crises involving painful blockages in small blood vessels, and organ damage. The condition is most common where malaria is endemic, as the sickle cell trait provides resistance to that disease. Laboratory testing can demonstrate sickle cells on blood smears and the presence of HbS on electrophoresis.
Hemoglobin D is a structural hemoglobin variant caused by a point mutation in the beta globin gene. This document discusses the history and molecular basis of Hemoglobin D, its distribution worldwide including prevalence in Pakistani and Indian populations, clinical manifestations in different genotypes including heterozygous, homozygous, and compound heterozygous states with other hemoglobinopathies like beta thalassemia. It also summarizes several case reports of Hemoglobin D-beta thalassemia published in medical literature.
Lysosomal storage disorders are a group of inherited metabolic diseases caused by deficiencies of lysosomal enzymes. This results in the accumulation of substrates in the lysosomes which causes cellular dysfunction. Some examples discussed include Gaucher disease, Tay-Sachs disease, Niemann-Pick disease, and Fabry disease. The document provides an overview of the causes and characteristics of these lysosomal storage disorders.
This document summarizes information about glucose-6-phosphate dehydrogenase (G6PD) deficiency. It discusses how G6PD is important for generating NADPH and reducing power in red blood cells. G6PD deficiency results in oxidative damage and hemolysis of red blood cells due to a lack of reducing equivalents. Clinical manifestations range from asymptomatic to acute hemolytic anemia triggered by oxidative drugs, infections, or fava beans. Diagnosis involves screening tests to detect low G6PD enzyme activity in red blood cells.
This document discusses megaloblastic anemia caused by vitamin B12 or folic acid deficiency. It covers the absorption and causes of deficiencies of these vitamins, clinical features including hematological and bone marrow findings, and biochemical tests to diagnose the deficiencies. The key tests mentioned are serum B12, methylmalonic acid, homocysteine, Schilling test, and red blood cell and serum folate levels. Guidelines are provided on interpretation of the test results in the clinical context.
Megaloblastic anemias are caused by impaired DNA synthesis due to vitamin B12 or folate deficiency. The summary examines megaloblastic anemias, including causes such as vitamin B12 or folate metabolism defects, clinical features like pallor and neurological symptoms, investigation findings in peripheral blood and bone marrow showing megaloblasts and macroovalocytes, and treatment involving vitamin B12 or folate supplementation.
This document provides an overview of macrocytic anemia, including:
- Megaloblastic anemia is caused by vitamin B12 or folate deficiency and results in large, immature red blood cells (megaloblasts) in the bone marrow.
- Non-megaloblastic macrocytic anemias have other causes and do not involve megaloblasts.
- Workup of macrocytic anemia includes evaluation of mean corpuscular volume, red cell distribution width, blood counts, serum B12 and folate levels, and bone marrow examination showing megaloblasts in megaloblastic anemia.
- Treatment depends on the underlying cause but commonly involves B
Porphyria is caused by deficiencies in enzymes involved in heme biosynthesis, leading to accumulation of porphyrins and their precursors. There are several types of porphyria classified by enzyme deficiency, symptoms, or origin of excess precursors. Acute porphyrias involve neurologic or abdominal symptoms, while cutaneous porphyrias cause skin problems when exposed to sunlight. Porphyria results from partial deficiencies in enzymes that are sufficient under normal conditions but can be exacerbated by external factors, causing intermediates to accumulate and spill over.
This document provides an overview of anemia, including its classification, causes, clinical features, laboratory diagnosis, and pathophysiology.
Anemia is defined as a hemoglobin level below the normal range based on age and sex. It can be classified based on red blood cell size (microcytic, normocytic, macrocytic) or pathophysiology (blood loss, impaired RBC production, increased RBC destruction). Common causes include iron deficiency, B12/folate deficiency, blood loss, hemolytic disorders, and bone marrow disorders.
Clinical features depend on the severity and speed of onset of anemia. Laboratory evaluation includes complete blood count, RBC indices, peripheral smear, and additional
This document provides information on anaemia, including its definition, epidemiology, pathophysiology, clinical features, investigations, classification, and management. It begins by defining anaemia as a decreased red blood cell mass that can be detected by low haemoglobin, haematocrit, and red blood cell count. Globally, anaemia prevalence is high in developing countries, especially among women and children in Africa. The pathophysiology involves inadequate red blood cell production due to iron deficiency, vitamin deficiencies, or chronic diseases. Common causes include iron deficiency, vitamin B12/folate deficiency, and anaemia of chronic disease. A complete blood count, peripheral smear, and targeted lab tests can help classify and diagnose the specific type of
This document discusses various laboratory investigations used in dentistry, including biopsies, hematological tests, urinalysis, and blood chemistry screens. It describes 10 different types of biopsies and their purposes. It also explains common hematological tests like complete blood count, erythrocyte sedimentation rate, and tests used to investigate bleeding disorders. Urinalysis and various blood chemistry screens are outlined that can provide information about conditions like diabetes, kidney function, and lipid levels.
This document provides an overview of anaemia, including:
1. Anaemia is defined as a low hemoglobin level and is classified based on red blood cell morphology and cause.
2. Common causes include deficiencies in iron, vitamin B12, or folate, blood loss, bone marrow disorders, and hemolytic anemias.
3. Signs and symptoms vary depending on severity and onset but may include pallor, weakness, and heart problems.
4. Diagnosis involves a complete blood count, peripheral smear to examine red blood cell size and shape, and other tests depending on the suspected cause.
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
Blood, its Disorders & Investigations in Paediatric Dentistry.pptxDr. Mukesh Kumar Dey
This document discusses blood disorders and investigations relevant to pediatric dentistry. It covers the components and functions of blood, as well as disorders that affect red blood cells like polycythemia vera, iron deficiency anemia, aplastic anemia, sickle cell anemia, and thalassemia. For each disorder, it describes the etiology, clinical manifestations, oral manifestations, laboratory findings, and management considerations. The document provides an overview of several important blood disorders that pediatric dentists may encounter.
Anemia is a condition in which there aren't enough healthy red blood cells to carry oxygen throughout the body.
The most common cause of Anemia is iron deficiency, and Anemia is the most common blood disorder in the world. This PDF is for those of you who are looking for a comprehensive overview of Anemia.
We'll go over the classification, clinical presentation, investigations, and mechanism of Anemia.
This document provides an overview of hematopoiesis, erythropoiesis, and anemia. It discusses where blood cell formation occurs, the lifespan and production rate of red blood cells, and how hypoxia stimulates erythropoietin production. It defines anemia, lists global and country prevalence data, and compensatory mechanisms. It describes classifications of anemia including morphological and etiological, and covers causes such as blood loss, bone marrow disorders, nutritional deficiencies, and hemolytic anemias. Laboratory evaluation of anemia and peripheral blood smear findings are also summarized.
p
r
r
1-Differentiate between the different causes of anemia
2. Discuss the investigations that may clarify the diagnosis
3. Recognize the predisposing factors and consequences of iron deficiency anemia and discuss how to manage it
4. Discuss the hereditary basis and clinical features of sickle cell anemia and thalassemia .
prepared by med_students0
The document provides an overview of tests used to assess the hematology system. It discusses the composition of blood including erythrocytes, leukocytes, platelets, and hematopoiesis. Diagnostic tests are outlined including complete blood count, coagulation tests, platelet aggregation test, leukocyte alkaline phosphatase test, serum iron tests, bone marrow examination, lymph node biopsy, and radiological studies. The goal of these tests is to evaluate blood cellular components, clotting ability, and detect any abnormalities in the hematology system.
The document discusses various types of anemia including their causes, symptoms, diagnostic tests, and treatment. It covers iron deficiency anemia, thalassemia, sickle cell anemia, hereditary spherocytosis, megaloblastic anemia, and aplastic anemia. The key signs and findings for each type are outlined along with recommended treatment approaches.
1. The document discusses the learning objectives and treatment of anemia.
2. It defines anemia and describes common signs and symptoms. Diagnosis involves a medical history, physical exam, and lab tests to identify the underlying cause and guide treatment.
3. Treatment options include nonpharmacological measures like diet changes and blood transfusions, as well as pharmacological therapies tailored to specific causes like oral or intravenous iron for iron deficiency anemia, and vitamin B12 injections for pernicious anemia.
This document provides an overview of red blood cells (RBCs) and red blood cell disorders. It begins with an introduction to RBCs and their characteristics. It then discusses the history of RBC discovery. The document outlines RBC production (erythropoiesis), hemoglobin, and normal RBC measurements like erythrocyte sedimentation rate and packed cell volume. Major sections cover RBC disorders like anemia, polycythemia, and conditions like iron deficiency anemia, sickle cell anemia, and thalassemia. Management approaches for certain disorders are also summarized.
This document provides an overview of anemia classification and diagnosis. It defines anemia as a decreased ability of blood to carry oxygen due to low hemoglobin or red blood cell counts. Anemia is caused by blood loss, destruction, deficient production, or abnormal hemoglobin. Diagnosis involves patient history, exam, and lab tests including complete blood count, reticulocyte count, and blood smear. These tests provide information on red blood cell counts, size, hemoglobin concentration, and morphology to classify anemia and identify underlying causes.
Haematopathology consists of dysplastic or neoplastic changes to normal blood and bone marrow cells. There are nearly 100 types of hematopoietic disorders categorized into anaemias, myeloid neoplasms, lymphoid neoplasms, and histiocytic/dendritic neoplasms. Advanced digital imaging technologies are used to diagnose these diseases by examining blood smears, bone marrow aspirates, and lymph node biopsies. The three major types of anaemia are those due to blood loss, poor red blood cell production, and red blood cell destruction.
This document summarizes several types of hemolytic anemias. It describes inherited hemolytic anemias caused by genetic defects in red blood cells, such as hereditary spherocytosis where red blood cells have a skeletal defect making them vulnerable to destruction. It also describes acquired hemolytic anemias caused by infections, toxins, or autoimmune disorders. Specific disorders discussed in detail include glucose-6-phosphate dehydrogenase deficiency, sickle cell anemia caused by a hemoglobin mutation, and thalassemias which are genetic anemias resulting from decreased hemoglobin chain synthesis.
This document discusses anemia, including its causes, types, symptoms, and diagnosis. It begins by defining anemia as an insufficient level of hemoglobin to supply tissues with adequate oxygen. Anemia is then classified based on red blood cell size (microcytic, normocytic, macrocytic), hemoglobin content (hypochromic, normochromic, hyperchromic), and pathophysiology (decreased red blood cell production, increased destruction, blood loss). Common causes are also listed for each type. The document concludes by outlining the process for diagnosing anemia, which involves patient history, physical exam, and laboratory tests such as complete blood count and blood smear analysis.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...RitikBhardwaj56
Discover the Simplified Electron and Muon Model: A New Wave-Based Approach to Understanding Particles delves into a groundbreaking theory that presents electrons and muons as rotating soliton waves within oscillating spacetime. Geared towards students, researchers, and science buffs, this book breaks down complex ideas into simple explanations. It covers topics such as electron waves, temporal dynamics, and the implications of this model on particle physics. With clear illustrations and easy-to-follow explanations, readers will gain a new outlook on the universe's fundamental nature.
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
4. Blood &Its Constituents
■ Blood is a specialized fluid connective
tissue comprising of 55% fluid plasma
and 45% formed elements.
■ Plasma (55%) is a straw colored clear
liquid part of blood. It contains 91-92%
of water and 8-9% of solids. Plasma
contains ions, water, proteins,
nutrients, wastes and gases.
■ The 45% formed elements comprises of
Erythrocytes (RBC’s) , Leukocytes
(WBC’s) and Thrombocytes (Platelets).
5.
6. Erythrocytes: Its Normal Shape & Size
■ Red Blood Cells are non-nucleated formed elements in
the blood. Red blood cells are also knows as
Erythrocytes; erythros = red.
■ Normal Shape: Disk Shaped and Biconcave (dumbbell
shaped). Central portion is thinner and Periphery is
thicker. The biconcave shape helps in equal and rapid
diffusion of oxygen and other substances inside the cell.
Also, the biconcave shape provides a larger surface
area for absorption or removal of different substances.
■ Normal Size:
Diameter: 7.2 μ (6.9 – 7.5 μ)
Thickness: 2.2-2.5 μ (periphery) and 1 μ (center)
Surface Area: 120 μ
Volume: 85 – 90 cu μ
7. Erythrocytes: Its Normal Value , Lifespan & Major
Component
■ Normal Value:- 5.5 ± 1.0 x 10²/L in
men and 4.8 ± 1.0 x 10²/L in
women.
■ Lifespan:- 120 days.
■ Major Component: Hemoglobin.
Hemoglobin consists of a basic
protein, globin and the iron-
poryphyrin complex, haem. The
Molecular weight of Hb is 68,000.
Hb Content in Man: 14.0 ± 2.5 g/dl.
Hb Content in Women: 11.5 – 16.5
g/dl.
8. Disorders Of Erythroid Series
■ The section of disorders of the
hematopoietic system is concerned with
diseases of the blood and the bone
marrow.
■ It comprises of discussion on diseases of
red blood cells, white blood cells,
platelets and bleeding disorders.
■ In this Presentation we will be dealing
with Anaemias and specifically Sickle
Cell Anaemia which forms an integral
part of Disorders of Erythroid Series.
9. Objectives:
■ Anemias- General Consideration, Pathophysiology, Clinical
Features and Classification of Anaemia.
■ Sickle Cell Anaemia: Type, Cause and Result.
■ Process Of Sickling.
■ Genetics Of Sickle Cell Anaemia.
■ Clinical Features.
■ Maxillofacial Manifestations.
■ Radiographic Features.
■ Laboratory Findings.
■ Histopathology and Treatment.
10. ANAEMIA-GENERAL CONSIDERATIONS
■ Definition: Anaemia is defined as reduced
haemoglobin concentration in blood
below the lower limit of the normal range
for the age and sex of the individual.
■ As per WHO, the lower extreme of the
normal Hb is taken as 13g/dl for adult
males and 12g/dl for adult females (11g/dl
in pregnant females). At birth, lower limit
of normal Hb level is 13g/dl whereas at 0-6
months the normal lower level is 10.5g/dl.
■ Parameter’s for determining person is
Anaemic or Not-
1. Haemoglobin value. (Major)
2. RBC count.
3. Haematocrit value- PCV
4. Absolute values- MCV, MCH and MCHC.
11. Pathophysiology Of Anaemia :-
■ Subnormal level of Haemoglobin causes lowered oxygen carrying
capacity of the blood. This in turn, initiates compensatory physiologic
adaptations such as follows:
1. Increased release of Oxygen from Haemoglobin.
2. Increased blood flow to the tissues.
3. Maintenance of the blood volume.
4. Redistribution of blood flow to maintain the cerebral blood supply.
Eventually, tissue hypoxia develops causing impaired function of the affected
tissues. Tissues with high oxygen requirement such as the heart, CNS and the
skeletal muscle during exercise, bear the brunt of clinical effects of anaemia.
12. General Clinical Features Of Anaemia:
■Symptoms: Tiredness, easy fatiguability, generalized muscular weakness,
lethargy and headache. In older patients, there may be symptoms of
cardiac failure, angina pectoris, confusion and visual disturbances.
■Signs: A few general signs common to all types of Anaemias are as under:
1. CVS- Tachycardia, collapsing pulse, congestive heart failure.
2. CNS- Faintness, Giddiness, Headache, drowsiness, numbness.
3. Reproductive Systems- Amenorrhoea, loss of libido.
4. Renal System- Mild Proteinuria, impaired concentrating capacity of the
kidney.
5. GIT- Constipation, weight loss, Nausea.
13.
14. Classification Of Anaemia
A] PATHO-PHYSIOLOGIC CLASSIFICATION:
I. Anaemia due to increased blood loss-
a) Acute post-haemorrhagic Anaemia
b) Chronic Blood Loss
II. Anaemia’s due to impaired red blood cell production-
a) Cytoplasmic Maturation Defects- Iron deficiency anaemia and Thalassemic anaemia.
b) Nuclear Maturation Defects- Megaloblastic Anaemia (Vit. B12/folic acid deficiency.)
c) Anaemia of Chronic Disorders.
d) Bone marrow infiltration.
e) Congenital Anaemia.
III. Anaemia’s due to increased red blood cell production/ Haemolytic Anaemia’s-
a) Extrinsic red cell abnormalities.
b) Intrinsic red cell abnormalities.
B] MORPHOLOGIC CLASSIFICATION:
a) Microcytic, Hypochromic.
b) Normocytic, Hypochromic.
c) Macrocytic, Hypochromic.
15. Most common hereditary disease
of blood world wide, transmitted
through autosomal dominant trait.
Cause: A single Point mutation in
the beta globin gene alters the
structure of the haemoglobin
produced.
Result: The abnormal or sickle
haemoglobin (HbS), replaces the
normal adult haemoglobin (HbA).
Sickle Cell Anaemia
16.
17. Process Of Sickling:
On Deoxygenation or low oxygen tension, HbS molecules begin to aggregate
and cause conversion of free flowing red blood cell cytosol to a viscous gel.
As deoxygenation continues, the aggregation increases and forms long needle
like fibres within the cell, producing the stiff, distorted sickle shaped erythrocytes.
The cumulative damage caused by repeated sickling eventually leads to
irreversible sickling of the cells.
The majority of these cells are destroyed rapidly by mononuclear phagocytes
(Extravascular Haemolysis) and remaining destroyed by intravascular haemolysis.
This haemolysis leads to sickle cell anaemia, and these cells cannot pass through
the microvasculature easily. They obstruct the microvasculature and cause tissue
hypoxia that promotes further sickling.
18.
19. Genetics Of Sickle Cell Anaemia:
Heterozygotes/Carriers: Individuals who inherit only one copy of
the HbS allele from one parent and a copy of HbA from the other
parent. This is also known as sickle cell trait.
Genotype- HbAHbS
Feature:
Haemoglobin in these individuals contain 40% HbS and 60% HbA.
They do not show sickling, unless they are experiencing severe
hypoxia.
Homozygotes/Sufferers: Sickle cell Anaemia is seen in individuals
who inherit HbS allele from both the parents.
Genotype- HbSS
Feature:
Haemoglobin in these individuals contain 100% HbS.
They show sickling of cells and severe hypoxia.
20. Clinical Features:-
■ Fatigue, exercise intolerance, and jaundice.
■ Pain in bones, joints, abdomen and neuropathic pain.
■ A lifetime of poor oxygen delivery and microvascular
occlusion can lead to damage in a number of organs
including spleen, brains, eyes, lungs, heart, liver,
kidneys, joints, bones, penis and skin.
■ Reduced growth, increased susceptibility to infections,
Stroke, Chronic renal failure, convulsions accompany
the damaged organs.
■ Most common crisis= Vasculo-occlusive crisis including
Pain crisis, Acute Chest Syndrome involving the lungs
and typically presents a combination of fever, cough
and chest pain and pulmonary infiltrates in affected
children. This condition is an medical emergency and
requires immediate treatment.
■ Sequestration Crisis: Medical emergency associated
with SCA. Most frequently seen in children below five
years of age. It leads to sudden spleen enlargement &
shock.
21. Low Power View Of Blood Smear. High Power View Of Blood Smear.
23. Maxillofacial Manifestations
■ Growth and development are often affected in individuals
with SCA.
■ Skeletal manifestations in maxillofacial region include:
1. Prominent cheekbones
2. Maxillary overgrowth
■ Occlusal manifestations include:
1. Increased overjet, overbite.
2. Increased Diastemata.
3. Delay in tooth eruption.
■ Chronic pain has been reported in TMJ.
■ Fibrous gingival enlargement.
■ No effect on dental caries.
■ Osteomyelitis is up to 200 times more common to individuals
with SCA than the ret of the population.
24. Radiographic Features
■ Osteoporosis between the apices of the posterior teeth and inferior
border of the mandible.
■ Mandible presents with a “step ladder” image on radiograph due to
increased intertrabecular spacing.
■ The vasculo-occlusive phenomenon causes a “bone within a bone”
image that represents an area of decalcification surrounded by
reactive sclerosis, demarcated from the remaining bone by a
radiolucent area.
■ Radiograph’s of Skull-
1. “Hair on end” pattern formed by perpendicular radiations
radiating outward from the inner table.
2. Diploe thickened.
25.
26. Laboratory Findings
Laboratory Values Of Blood Indices-
■ Haemoglobin Level- 5-9g/dl
■ Haematocrit values- below 17-29%
■ Reduced ESR, elevated total leukocyte count to 12,000-20,000 cells/mm³, with a
predominant neutrophil component, increased platelet and reticulocyte count.
■ RBC count- 1,00,000 cells or less per mm³ with a decreased haemoglobin level.
Diagnostic Test:- Haemoglobin analysis by protein electrophoresis or liquid
chromatography.
A diagnosis od SCA is seen when the tests show absence of HbA in adults and a less
than 30% component of HbF in infants.
Electrophoresis can also differentiate between Sickle Cell Anaemia and Sickle Cell
Trait.
Blood Smear- Variable number of irreversibly sickled RBC, Target cells and Howell-
Jolly bodies.
27. Facts Of Life:
■ Howell-Jolly Bodies: Basophilic
nuclear remanants in circulating
erythrocytes. During maturation,
late erythroblasts normally expel
their nuclei; but, in some cases a
small portion of DNA remains.
■ Sickle Cell Trait provides a
survival advantage, against
malaria fatality, over people with
normal Hb in regions where
malaria is endemic. The Trait is
known to cause fewer deaths
due to malaria especially when P.
falciparum is the causative
organism.
28.
29. Histo-Pathology
■ Nuclear enlargement, binucleation and an abnormal chromatin
distribution.
Treatment
• Check up every 3-12 months depending on their age.
• Adults, treated with hydroxyurea and if possible bone marrow
transplantation, which is the only curative option.
30. Reference's:-
■ Robbins Pathology- Sixth Edition
■ Medical Sembulingam-Physiology
■ Harsh Mohan – Pathology
■ Shafer’s Textbook Of Oral Pathology
■ Google